Trials / Active Not Recruiting
Active Not RecruitingNCT06106256
Three-Axis Wearable Adaptive Vestibular Stimulator
3WAVeS: Three-Axis Wearable Adaptive Vestibular Stimulator
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 21 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to improve current galvanic vestibular stimulation (GVS) technology to ease the motion sickness often associated with virtual reality (VR) simulation.
Detailed description
The Three-Axis Wearable Adaptive Vestibular Stimulator (3WAVeS) technology that combines galvanic vestibular stimulation (GVS) and Virtual Reality (VR) will not only increase VR-based simulation realism and presence, but will also mitigate the motion sickness often associated with VR simulation by re-coupling the vestibular and ocular inputs to the VR user. Additionally, due to GVS technology's ability to accurately provide continuous inputs to the vestibular system, 3WAVeS can intentionally simulate high-fidelity effects of spatial disorientation for training purposes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Galvanic Vestibular Stimulation (GVS) | Four electrodes, forehead, behind both ears, and back of your neck, provide bidirectional electrical stimulation and receive information about the amplitude delivered accounting for skin impedance |
| OTHER | Flight simulations in virtual reality (VR) | Highly immersive, 3D virtual flight simulation environment |
| OTHER | 3-DOF Bertec Portable Essential's dual-balance force plate system | Firm surface/plate to stand on while being presented disorienting visual patters of moving vertical and/or horizontal bars of alternating black and white. |
Timeline
- Start date
- 2023-11-15
- Primary completion
- 2025-12-10
- Completion
- 2026-12-01
- First posted
- 2023-10-30
- Last updated
- 2026-01-30
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06106256. Inclusion in this directory is not an endorsement.